Form D · Pharmaceuticals
Amplicore Inc.
Cincinnati, OH · CIK 0001799004
Offering snapshot reported Jan 7, 2020 · SEC filing
- Reported sold
- $2.82M Offering amount: $5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 24, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2020 | Initial | $2,816,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-357421
Source: Form D, filed Jan 7, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Felix Chang | Director, Executive |
| Yi Ju Chen | Director, Executive |
| Chia Ying James Lin | Director, Executive |
| Chiu S. Lin, Ph.D. | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1819 Innovation Hub 2900 Reading Road, Suite 260
Cincinnati, OH, 45206
Cincinnati, OH, 45206